Evolus (EOLS) Income towards Parent Company (2017 - 2026)
Evolus (EOLS) reported Income towards Parent Company of -$10.7 million for Q1 2026, up 43.5% on a YoY basis from -$7.4 million in Q1 2025, and down 8310.77% quarter-over-quarter from $130000.0 in Q4 2025.
Evolus (EOLS) Income towards Parent Company (2017 - 2026) Analysis & Trends
Evolus has reported Income towards Parent Company for 10 years, with the latest figure at -$10.7 million in Q1 2026.
- For the quarter ending Q1 2026, Income towards Parent Company rose 43.5% year-over-year to -$10.7 million; the trailing twelve-month figure through Mar 2026 stood at -$43.4 million (up 22.74% YoY), and the FY2025 full-year result was -$51.6 million, down 2.42% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$10.7 million, down from $130000.0 in the prior quarter.
- The five-year high for Income towards Parent Company was $130000.0 in Q4 2025, with the low at -$23.5 million in Q2 2022.
- Historically, Income towards Parent Company has averaged -$14.6 million across 5 years, with a median of -$15.7 million in 2025.
- Annual changes were most pronounced in 2022 — Income towards Parent Company plunged 373.41% — and 2025, when it soared 101.91%.
- Evolus' Income towards Parent Company stood at -$13.2 million in 2022, then rose by 10.13% to -$11.8 million in 2023, then jumped by 42.6% to -$6.8 million in 2024, then surged by 101.91% to $130000.0 in 2025, then slumped by 8310.77% to -$10.7 million in 2026.
- The last three Income towards Parent Company figures came in at -$10.7 million (Q1 2026), $130000.0 (Q4 2025), and -$15.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Evolus | 439.03 Mn | 389.24 Mn | 48.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.67 Mn |
| Dec 31, 2025 | 130,000.00 |
| Sep 30, 2025 | -15.74 Mn |
| Jun 30, 2025 | -17.14 Mn |
| Mar 31, 2025 | -18.89 Mn |
| Dec 31, 2024 | -6.79 Mn |
| Sep 30, 2024 | -19.17 Mn |
| Jun 30, 2024 | -11.35 Mn |
| Mar 31, 2024 | -13.11 Mn |
| Dec 31, 2023 | -11.83 Mn |
| Sep 30, 2023 | -16.92 Mn |
| Jun 30, 2023 | -18.14 Mn |
| Mar 31, 2023 | -14.79 Mn |
| Dec 31, 2022 | -13.16 Mn |
| Sep 30, 2022 | -20.28 Mn |
| Jun 30, 2022 | -23.47 Mn |
| Mar 31, 2022 | -17.50 Mn |
| Dec 31, 2021 | -18.18 Mn |
| Sep 30, 2021 | -19.43 Mn |
| Jun 30, 2021 | -15.60 Mn |